Clinical Anesthesia Procedures
- Dabigatran
- Damage control surgery
- DBD
- Deep brain stimulators
- Defibrillation
- Delirium
- Denosumab
- Dentistry and oral and maxillofacial surgery
- DES
- Desmopressin (DDAVP)
- Desmopressin acetate (DDAVP)
- Desmopressin Acetate (DDAVP)
- Dexamethasone
- Dexamethasone (Decadron)
- DHP
- DI
- Diabetes insipidus
- Diabetes insipidus (DI)
- Diabetic ketoacidosis (DKA)
- Diaphoresis
- Diazepam
- Digoxin
- Dihydropyridine (DHP)
- Dilantin
- Diltiazem
- Diltiazem (Cardizem)
- Dimenhydrinate
- Dipyridamole
- Direct and Indirect Conditions That Place Patients at Risk of Developing ARDS (Table 4.1)
- Direct factor Xa inhibitors
- Direct laryngoscopy
- Direct thrombin inhibitors (DTIs)
- Diuretics (Table 5.4)
- DKA
- Donation after brain death (DBD)
- Dopaminergic
- Doppler ultrasound
- Dosages of Commonly Used IV Anesthetics and Induction Dose Onset and Duration (Table 12.1)
- Dose, Time to Peak Effect, and the Duration of Analgesia for Intravenous Opioid Agonists and Agonist-Antagonistsa (Table 12.2)
- Doxazosin
- DPE
- Droperidol
- Drug Dosages of Commonly Used Vasopressors and Inotropes (Table 18.2)
- Drug-eluting stents (DES)
- Drugs and Dosages (in mg) for Spinal Anesthesia (Table 20.2)
- DTIs
- Duchene muscular dystrophy
- Dural puncture epidural (DPE)
- Dysphagia
- Dyspnea